Company goal

We are experts and our mission is to create innovations in the development, production and implementation of efferent devices that will provide new opportunities for clinicians and have an effective impact on restoring the health and quality of life of millions of people around the world.

Our goal

- in every frame

"Orisil-Pharm" is a Ukrainian pharmaceutical company - an expert in the field of development, implementation and production of innovative efferent agents in medicine and veterinary medicine.

Our specialization is the creation of new forms and types of efferent agents based on nanodispersed silicon dioxide and the development of new methods of their application. We are confident that efferent methods are the future in the therapy and prevention of diseases, because the removal of pathogenic elements from the body, without causing a negative impact on various organs and systems, is a truly revolutionary technology.

Creation of innovative efferent therapy drugs

Quality

Creating Ukrainian drugs that meet leading European quality standards is the main priority of Orisil-Pharm! We implement quality principles at all stages of production and non-production processes.
All our products are manufactured in accordance with GMP (Good Manufacturing Practice) standards. This is a practice that ensures that the drug and active ingredient are manufactured and controlled in accordance with prescribed standards and regulations in accordance with the requirements set out in the specifications and documents on the basis of which their marketing authorizations are issued.

The Quality Assurance Department supervises the implementation of requirements and compliance with the implemented quality systems, and constantly improves them. This is confirmed by a number of audits passed and certificates obtained: GMP, ISO13485, HACCP. We guarantee that each product we manufacture is safe for the patient and for each of our preparations we use only the highest quality ingredients.

Innovation

Orisil-Pharm is an expert in the field of development, production and implementation of efferent means and methods in clinical practice. We realize our goal by applying our accumulated many years of experience, high-quality professional knowledge, through research projects in the field of medicine and pharmacy, to create innovative means, methods and principles. We are in constant search and research that will open up new opportunities for restoring people's health.

Care

We pay attention and provide assistance primarily to those who cannot take care of themselves. Our social and volunteer projects are aimed at helping orphanages, low-income patients, and soldiers in the ATO zone.

Orisil-Pharm uses economical approaches in the production process. We rationally use raw materials and waste, thus taking care of our environment. We have implemented the Ecomanagement System in production and all unnecessary products that are formed in the production process are disposed of in an environmentally friendly way. We are implementing a complex of energy-saving production technologies at the enterprise.

Through innovation – to leadership

The main strategy of the company "Orisil-Pharm" is "Through innovation - to leadership", which reflects our desire for leadership positions in the market, expanding our activities in both Ukrainian and foreign markets, and the focus on innovation allows us to conduct new research and develop and bring to the market innovative efferent agents in medicine and veterinary medicine.

Adhering to the basic principles of work that leading specialists follow in the production process, as well as understanding our great responsibility to society, our team helps improve existing and provides new opportunities for clinicians to act more effectively and safely to preserve and restore the health of our patients.

Company history

2003

2005

2007

2007-2012

2012

2012-2019

2017

Year of foundation

On October 16, 2003, the company “Orisil-Pharm” was founded by the couple Kishchak Maksym and Natalia, a tandem of a doctor and a pharmacist. The company “Orisil-Pharm” was created as the pharmaceutical division of the company “Orisil”, which is the leading manufacturer of pyrogenic silicon dioxide in the CIS and Eastern European countries, as well as one of the four largest manufacturers in the world.

First production

The production of the drug “Atoksil” was first started at the Lviv Pharmaceutical Factory. By this period, the drug “Atoksil” had passed all stages of clinical trials and received the relevant registration documents.

Opening of our own production complex

In 2007, the company invested the first funds in the construction and opening of its own production complex in the city of Kalush, Ivano-Frankivsk region. All stages of preparatory work were carried out: obtaining permits, licenses and certificates, ensuring production in accordance with global standards of good manufacturing practice.

Development of production activities

2007-2012 is a period of dynamic development of production activities. Expansion of the range of manufactured products, creation of new production lines and sites.

Passing the licensing procedure

In 2012, the company “Orisil-Pharm” underwent a licensing procedure according to new standards, and as a result received a perpetual license for the production of medicinal products and a certificate of compliance with GMP requirements.

Certification

During 2012-2019, the company was certified for compliance with ISO:13485, HACCP standards.

Access to foreign markets

In 2017, the company first entered foreign markets with the drugs Eliminal Gel and Alko-sorb; currently, the company's drugs are supplied to six countries around the world.

22 years of growth and leadership

Over the past 22 years, the company has tripled its production area, launched four gel production sites, and holds a leading position in the market of efferent therapy drugs. Orisil-Pharm drugs are high-quality Ukrainian drugs that are recognized both among the professional medical and pharmaceutical community and among patients.

We are grateful for the trust and support that inspires us to work, develop, and develop modern and effective drugs to restore the health and quality of life of millions of people!